Lithium protection against glutamate excitotoxicity in rat cerebral cortical neurons: involvement of NMDA receptor inhibition possibly by decreasing NR2B tyrosine phosphorylation.
about
Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorderThe role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesisA new look at an old drug: neuroprotective effects and therapeutic potentials of lithium saltsBeyond Monoamines-Novel Targets for Treatment-Resistant Depression: A Comprehensive ReviewAntidepressant mechanism of ketamine: perspective from preclinical studiesNo benefit from chronic lithium dosing in a sibling-matched, gender balanced, investigator-blinded trial using a standard mouse model of familial ALSChronic Microdose Lithium Treatment Prevented Memory Loss and Neurohistopathological Changes in a Transgenic Mouse Model of Alzheimer's DiseaseMolecular actions and clinical pharmacogenetics of lithium therapySynergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibitionInvolvement of the glycogen synthase kinase-3 signaling pathway in TBI pathology and neurocognitive outcomeThe host range of gammaretroviruses and gammaretroviral vectors includes post-mitotic neural cellsChronic treatment with mood-stabilizers attenuates abnormal hyperlocomotion of GluA1-subunit deficient miceValproic acid induces functional heat-shock protein 70 via Class I histone deacetylase inhibition in cortical neurons: a potential role of Sp1 acetylationAdvances in the treatment of anxiety: targeting glutamate.Research in people with psychosis risk syndrome: a review of the current evidence and future directionsNeurons derived from transplanted neural stem cells restore disrupted neuronal circuitry in a mouse model of spinal cord injury.A systematic review of existing data on long-term lithium therapy: neuroprotective or neurotoxic?Beneficial effects of mood stabilizers lithium, valproate and lamotrigine in experimental stroke models.A new avenue for lithium: intervention in traumatic brain injury.Lithium-induced inhibition of Src tyrosine kinase in rat cerebral cortical neurons: a role in neuroprotection against N-methyl-D-aspartate receptor-mediated excitotoxicity.Protocol for a double-blind randomised placebo-controlled trial of lithium carbonate in patients with amyotrophic lateral sclerosis (LiCALS) [Eudract number: 2008-006891-31].Preclinical and clinical investigations of mood stabilizers for Huntington's disease: what have we learned?The synaptic localization of NR2B-containing NMDA receptors is controlled by interactions with PDZ proteins and AP-2.Brain glutamate levels measured by magnetic resonance spectroscopy in patients with bipolar disorder: a meta-analysis.Glutamatergic modulators: the future of treating mood disorders?Valproate alters dopamine signaling in association with induction of Par-4 protein expressionNeuroprotection by valproic Acid in mouse models of permanent and transient focal cerebral ischemia.The underlying neurobiology of bipolar disorderLithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial.Neuroprotective effects of lithium in cultured cells and animal models of diseases.Proof of concept trials in bipolar disorder and major depressive disorder: a translational perspective in the search for improved treatments.NMDA receptor antagonists augment antidepressant-like effects of lithium in the mouse forced swimming test.Methamphetamine differentially affects BDNF and cell death factors in anatomically defined regions of the hippocampus.Postinsult treatment with lithium reduces brain damage and facilitates neurological recovery in a rat ischemia/reperfusion model.Inhibition of glycogen synthase kinase-3β prevents remifentanil-induced hyperalgesia via regulating the expression and function of spinal N-methyl-D-aspartate receptors in vivo and vitro.GSK-3 as a Target for Lithium-Induced Neuroprotection Against Excitotoxicity in Neuronal Cultures and Animal Models of Ischemic Stroke.Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disordersNeuroprotective action of lithium in disorders of the central nervous system.Novel glutamatergic agents for major depressive disorder and bipolar disorder.Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers.
P2860
Q24626017-8287F138-F051-4184-B3A7-7CBDBD9DCBB3Q24651407-175D49E5-6B94-4E20-B468-92F8755F3CA2Q26741164-71126FCD-4AD1-4603-8171-1A9A41166FA4Q26782993-298D7557-1405-4E9A-A4E3-B3F88017C132Q26800231-B98583F6-E7F1-42DD-BD34-54F36E7A038DQ27345515-C3568E67-50BC-4CFA-BADB-8A3193F1A77EQ27346441-7F3B37C1-CA1B-4D9D-8FA5-30A582FD952CQ28307770-7C7AB4CF-6644-4CFF-A543-958A2A8A9556Q28468536-E0270411-0272-4761-AF8A-3286A4772EF8Q28477096-147384C4-6036-468E-B361-1C53BEBDB5BCQ28477536-47F722CD-EF83-402C-9C3E-3C5A4D663C42Q28539744-C09F85AF-FE96-4102-B078-45AA011CE2CEQ28572236-0611A263-CFB5-40AA-AEFE-530708531998Q30457479-1F8891AC-E48A-41D7-AC29-BB6EC9FBF53FQ30475598-1A3282DB-C0E1-4516-B3E0-B757DF650D1FQ30496325-717EEB56-E4BD-4702-AF96-B5814DA52C51Q33284843-FB0CC025-08F1-47C7-B9B7-2B8169C8CD68Q33566724-D526034D-CD70-4183-82AB-762F90BDB1DFQ33777980-F6916FDC-EB21-47A0-9CC2-8F99F548E466Q33964873-CA41564C-B929-403F-AF63-CD5CDA54EFDFQ34026859-EAF8220B-FD3F-4B6F-B602-AC972802A008Q34284039-6BA05D5B-C483-48EA-891B-6C1A5A24713EQ34312604-E1F4655F-96D1-4895-8B8B-11759553B0AAQ34352492-1310D425-CD54-455E-964F-4EE15EF04319Q34398007-3AC02EF0-5A79-4203-A992-D7D886BD11A7Q34429621-58B9AF8C-244B-4934-86B7-0E36EEA52684Q34554054-49494A50-A953-4130-A94E-5CC7DA095A86Q34562614-374C4221-B5ED-47FC-BAD8-8577A3234BAFQ34648924-8E248117-FC0A-4A98-AC17-2DA4E29B3D6EQ34692758-6C48B47E-F2E2-40C4-8EC4-3C58462A1106Q34766451-D358CD70-9879-4D46-94D4-79492D3550EBQ34974649-0E29BB16-1BE1-4D37-92BF-F503C7A24041Q34982877-28A4580F-A3BF-4F79-BE3C-0E5EACD16698Q35023242-0A5CC723-D9D0-4002-8859-78F7FB568C03Q35023408-EFF027B6-6610-4E46-B864-BAD2FB1F7E83Q35154467-3116E83D-3C74-48F2-9430-226A98655C96Q35197096-63F8B4B8-5D65-48AF-9DF1-3947BBA4D0C8Q35212429-747FEFF7-73D2-404A-9E25-F069308393EEQ35661119-354F3A49-69A3-4151-9E57-FE99EC557E56Q35770186-9345EB9D-1921-4AD3-A35B-873F8468343C
P2860
Lithium protection against glutamate excitotoxicity in rat cerebral cortical neurons: involvement of NMDA receptor inhibition possibly by decreasing NR2B tyrosine phosphorylation.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Lithium protection against glu ...... NR2B tyrosine phosphorylation.
@ast
Lithium protection against glu ...... NR2B tyrosine phosphorylation.
@en
type
label
Lithium protection against glu ...... NR2B tyrosine phosphorylation.
@ast
Lithium protection against glu ...... NR2B tyrosine phosphorylation.
@en
prefLabel
Lithium protection against glu ...... NR2B tyrosine phosphorylation.
@ast
Lithium protection against glu ...... NR2B tyrosine phosphorylation.
@en
P2093
P1476
Lithium protection against glu ...... NR2B tyrosine phosphorylation
@en
P2093
Christopher Hough
De-Maw Chuang
Tadashi Yamamoto
Takanobu Nakazawa
P304
P356
10.1046/J.0022-3042.2001.00728.X
P407
P577
2002-02-01T00:00:00Z